PreveCeutical Medical (TSE:PREV) has released an update.
PreveCeutical Medical Inc. announces a delay in filing its 2023 annual financial statements due to funding issues, resulting in a Management Cease Trade Order. The company has engaged auditors with an expected completion date no later than June 28, 2024, and plans a private placement to raise capital for working capital and audit fees. Share trading continues for the public but is restricted for company insiders until the filings are complete.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
